Effects of pH-sensitive nanoparticles prepared with different polymers on the distribution, adhesion and transition of Rhodamine 6G in the gut of rats

References

• Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly(acrylic acid) derivative. Pharm Res 1995; 12: 397–405
   PubMed Web of Science ®Google Scholar
• Arbó P, Campanero MA, Arangoa MA, Renedo MJ, Irache JM. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Contr Rel 2003; 89: 19–30
   PubMedGoogle Scholar
• Arifin DY, Lee LY, Wang C-H. Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Del Rev 2006; 58: 1274–1325
   PubMed Web of Science ®Google Scholar
• Dai J, Nagai T, Wang X, Zhang T, Meng M, Zhang Q. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm 2004; 280: 229–240
   PubMed Web of Science ®Google Scholar
• Davis SS. Formulation strategies for absorption windows. Drug Disc Today 2005; 10: 249–257
   PubMed Web of Science ®Google Scholar
• De Jaeghere F, Alléann E, Kubel F, Galli B, Cozens R, Doelker E, Gurny R. Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J Contr Rel 2000; 68: 291–298
   PubMed Web of Science ®Google Scholar
• Deng Z, Xu S, Li S. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int J Pharm 2008; 351: 236–243
   PubMed Web of Science ®Google Scholar
• Florence AT. Nanoparticle uptake by the oral route: fulfilling its potential?. Drug Disc Today Technol 2005; 2: 75–81
   PubMedGoogle Scholar
• Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T, Langguth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Del Rev 2007; 59: 419–426
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J Pharm Sci 1989; 78: 68–72
   PubMed Web of Science ®Google Scholar
• Kim M-S, Jin S-J, Kim J-S, Park HJ, Song H-S, Neubert RHH, Hwang S-J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2008; 69: 454–465
   PubMed Web of Science ®Google Scholar
• Lahnstein K, Schmehl T, Rusch U, Rieger M, Seeger W, Gessler T. Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung. Int J Pharm 2008; 351: 158–164
   PubMedGoogle Scholar
• Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 2001; 18: 788–793
   PubMed Web of Science ®Google Scholar
• Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. J Pharm Sci 2003; 92: 2057–2068
   PubMed Web of Science ®Google Scholar
• Leroux JC, Cozens R, Roesel JL, Galli B, Kubel F, Doelker E, Gurny R. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or biodegradable or enteric nanoparticles s following intravenous and oral administration to mice. J Pharm Sci 1995; 84: 1387–1391
   PubMed Web of Science ®Google Scholar
• Leroux JC, Cozens RM, Roesel JL, Galli B, Doelker E, Gurny R. pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs. Pharm Res 1996; 13: 485–487
   PubMed Web of Science ®Google Scholar
• Li M-G, Lu W-L, Wang J-C, Zhang X, Wang X-Q, Zheng A-P, Zhang Q. Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm 2007; 329: 182–191
   PubMed Web of Science ®Google Scholar
• McDowell A, McLeod BJ. Physiology and pharmacology of the brushtail possum gastrointestinal tract: relationship to the human gastrointestinal tract. Adv Drug Del Rev 2007; 59: 1121–1132
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 2008; 36: 43–48
   PubMed Web of Science ®Google Scholar
• Rhowe RC, Sheskey PJ, Weller PJ, Zheng J-M. Handbook of pharmaceutical Excipients. Beijing Chemical Industry Press. 2004
   Google Scholar
• Sakuma S, Ogura R, Sakuma S, Ogura R, Masaoka Y, Kataoka M, Tanno FK, Kokubo H, Yamashita S. Correlation between in vitro dissolution profiles from enteric-coated dosage forms and in vivo absorption in rats for high-solubility and high-permeability model drugs. Journal of pharmaceutical sciences 2009, www.interscience.wiley.com.2009. DOI: 10.1002/jps.21716
   PubMedGoogle Scholar
• Shekunov BY, Chattopadhyay P, Seitzinger J, Huff R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm Res 2006; 23: 196–204
   PubMed Web of Science ®Google Scholar
• Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Contr Rel 2004; 98: 231–244
   PubMed Web of Science ®Google Scholar
• Wang XQ, Dai JD, Chen Z, Zhang T, Xia GM, Nagai T, Zhang Q. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J Contr Rel 2004; 97: 421–429
   PubMed Web of Science ®Google Scholar
• Wang XQ, Dai JD, Zhang H, Zhang X, Wang JC, Zhang Q. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol 2008; 8: 2422–2431
   PubMed Web of Science ®Google Scholar
• Watts PJ, Barrow L, Steed KP, Wilson CG, Spiller RC, Melia CD, Davies MC. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int J Pharm 1992; 87: 215–221
   Web of Science ®Google Scholar
• Yoncheva K, Guembe L, Campanero MA, Irache JM. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int J Pharm 2007; 334: 156–165
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006; 27: 262–270
   PubMed Web of Science ®Google Scholar